Q4 2018 Holdings
Filed 2019-02-14 | 69 holdings | $16.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $11.3M | 154,637 | 69.0% |
| Align Technology Inc(ALGN) | COM | 016255101 | $3.7M | 17,847 | 22.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.1M | 380,812 | 6.6% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $11.9K | 131,115 | 0.1% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $11.7K | 268,388 | 0.1% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $10.0K | 133,934 | 0.1% |
| Cigna Corp(CI) | COM | 125523100 | $9.9K | 52,216 | 0.1% |
| Amgen Inc(AMGN)Put | PUT | 031162100 | $9.7K | 50,000 | 0.1% |
| CVS Health Corp(CVS) | COM | 126650100 | $9.5K | 144,777 | 0.1% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $9.3K | 209,009 | 0.1% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $8.5K | 68,039 | 0.1% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $8.2K | 84,186 | 0.1% |
| Novo Nordisk A/S(NVO) | ADR | 670100205 | $6.8K | 147,378 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $6.6K | 102,390 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $6.3K | 2,373,841 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $6.0K | 96,480 | 0.0% |
| Urovant Sciences LTD | SHS | G9381B108 | $5.3K | 807,860 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $5.1K | 46,530 | 0.0% |
| Mylan NV | SHS EURO | N59465109 | $5.1K | 187,175 | 0.0% |
| Premier Inc(PINC) | CL A | 74051N102 | $5.0K | 134,412 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $5.0K | 2,180,546 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $5.0K | 42,869 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.9K | 69,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.9K | 637,046 | 0.0% |
| Bionano Genomics Inc(BNGOUSD) | *W EXP 08/21/2023 | 09075F107 | $4.9K | 1,436,461 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $4.7K | 443,409 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $4.7K | 16,317 | 0.0% |
| Emergent Biosolutions Inc(EBS) | COM | 29089Q105 | $4.4K | 73,793 | 0.0% |
| Penumbra Inc(PEN)Put | PUT | 70975L107 | $4.2K | 34,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $4.1K | 1,151,510 | 0.0% |
| RA Medical Systems Inc | COM | 74933X104 | $3.9K | 486,107 | 0.0% |
| Smith & Nephew PLC(SNN) | SPDN ADR NEW | 83175M205 | $3.8K | 102,163 | 0.0% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $3.6K | 35,144 | 0.0% |
| Becton Dickinson and Co(BDX) | COM | 075887109 | $3.6K | 16,000 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $3.5K | 14,207 | 0.0% |
| Abbott Laboratories(ABT) | COM | 002824100 | $3.5K | 48,737 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $3.4K | 167,724 | 0.0% |
| Medpace Holdings Inc(MEDP) | COM | 58506Q109 | $3.3K | 63,180 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $3.3K | 17,000 | 0.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $3.3K | 30,000 | 0.0% |
| Icon PLC(ICLR) | SHS | G4705A100 | $2.8K | 21,566 | 0.0% |
| Osmotica Pharmaceuticals PLC | SHS | G6S41R101 | $2.7K | 346,410 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $2.6K | 50,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $2.5K | 281,914 | 0.0% |
| Dentsply Sirona Inc(XRAY) | COM | 24906P109 | $2.4K | 65,666 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $2.3K | 291,625 | 0.0% |
| Hill-Rom Holdings Inc(HRC) | COM | 431475102 | $2.2K | 24,682 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.0K | 144,411 | 0.0% |
| Imprimis Pharmaceuticals, Inc.(HROW) | COM NEW | 415858109 | $1.9K | 335,364 | 0.0% |
| Vical Inc | COM NEW | 925602203 | $1.9K | 1,615,887 | 0.0% |